IP Library Granted Patent US 10,799,450
Granted Patent B2
US 10,799,450 · App. 16/289,770 · Granted Oct 13, 2020

Tableted cannabinoid chewing gum with layered structure

Inventors: Heidi Ziegler Bruun (Vejle O, DK); Dorthe Schackinger Boesen (Vejle, DK); Ane Eriksen (Vejle, DK)
Assignee: MedCan Pharma A/S
A61K9/0058A23G4/08A23G4/10A23G4/12A23G4/20A61K31/352A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,799,450
App. No.
16/289,770
Granted
Oct 13, 2020
Kind
B2
Abstract

The present invention relates to a tableted chewing gum composition for oral administration of cannabinoids, the composition comprising a plurality of particles, including a first population of particles comprising water-insoluble gum base and a second population of particles comprising water-soluble chewing gum ingredients, and the composition constituting at least two layers, wherein a first layer of the composition comprises water-insoluble gum base and a second layer of the composition, which is cohered to and adjacent to the first layer, comprises water-soluble chewing gum ingredients, the second layer being free of water-insoluble gum base, and wherein the composition comprises one or more cannabinoids.

Claims (32)

1. A tableted chewing gum composition for oral administration of cannabinoids, the composition comprising a plurality of particles, including a first population of particles comprising water-insoluble gum base and a second population of particles comprising water-soluble chewing gum ingredients, and the composition constituting at least two layers, wherein

a) a first layer of the composition comprises water-insoluble gum base and

b) a second layer of the composition, which is cohered to and adjacent to the first layer, comprises water-soluble chewing gum ingredients, the second layer being free of water-insoluble gum base, and

wherein the composition comprises one or more cannabinoids.

2. The tableted chewing gum composition according to claim 1 , wherein the composition consists of two layers where the first layer is cohered to and adjacent to the second layer.

3. The tableted chewing gum composition according to claim 1 , wherein the weight ratio of the first layer relative to the second layer is from 1:10 to 10:1.

4. The tableted chewing gum composition according to claim 1 , wherein the composition consists of three layers where the first layer is the middle layer, and the second layer is cohered to and adjacent to one side of the first layer, and a third layer is cohered to and adjacent to the opposite side of the first layer.

5. The tableted chewing gum composition according to claim 4 , wherein the weight ratio of the first layer relative to the second layer relative to the third layer is from 1:5:5 to 10:1:1.

6. The tableted chewing gum composition according to claim 1 , wherein the content of water-insoluble gum base of the first layer is more than 30% by weight of the first layer.

7. The tableted chewing gum composition according to claim 1 , wherein the content of water-soluble chewing gum ingredients of the second layer is more than 50% by weight of the second layer.

8. The tableted chewing gum composition according to claim 1 , wherein the first layer of the tableted chewing gum composition comprises the first population of particles in an amount of 20 to 60% by weight of the first layer.

9. The tableted chewing gum composition according to claim 1 , wherein the first layer of the tableted chewing gum composition comprises the second population of particles in an amount of 40 to 80% by weight of the first layer.

10. The tableted chewing gum composition according to claim 1 , wherein the content of water-insoluble gum base of the first population of particles is more than 30% by weight of the first population of particles.

11. The tableted chewing gum composition according to claim 1 , wherein the content of water-soluble chewing gum ingredients of the second population of particles is more than 50% by weight of the second population of particles, the second population of particles being free of water-insoluble gum base.

12. The tableted chewing gum composition according to claim 1 , wherein the water-soluble chewing gum ingredients comprise one or more sugar alcohols or one or more sugars in an amount of 35-80% by weight of the tableted chewing gum composition.

13. The tableted chewing gum composition according to claim 1 , wherein the one or more cannabinoids are part of the water-soluble chewing gum ingredients.

14. The tableted chewing gum composition according to claim 1 , wherein the one or more cannabinoids are present in the second population of particles comprising water-soluble chewing gum ingredients.

15. The tableted chewing gum composition according to claim 1 , wherein the one or more cannabinoids are located in the second layer of the chewing gum composition.

16. The tableted chewing gum composition according to claim 1 , wherein the one or more cannabinoids are both comprised in the first layer of the chewing gum composition and in the second layer of the chewing gum composition.

17. The tableted chewing gum composition according to claim 1 , wherein the gum base comprising one or more natural resins in an amount of 10-40% by weight of the gum base, one or more elastomers in an amount of 3-30% by weight of the gum base, and one or more elastomer plasticizers in an amount of 8-50% by weight of the gum base.

18. The tableted chewing gum composition according to claim 1 , wherein the gum base comprises less than 50% by weight of gum base polymers.

19. The tableted chewing gum composition according to claim 1 , wherein the release rate of the one or more cannabinoids is at least 30% by weight of the one or more cannabinoids within the first 5 minutes upon oral administration.

20. The tableted chewing gum composition according to claim 1 , wherein the one or more cannabinoids are present in an amount of 0.1 to 200 mg.

21. The tableted chewing gum composition according to claim 1 , wherein the one or more cannabinoids comprise cannabidiol (CBD), cannabidiolic acid (CBDA), cannabidivarin (CBDV), salts and derivatives thereof.

22. The tableted chewing gum composition according to claim 1 , wherein the one or more cannabinoids comprise tetrahydrocannabinol (THC), tetrahydrocannabinolic acid (THCA), tetrahydrocannabivarin (THCV), salts and derivatives thereof.

23. The tableted chewing gum composition according to claim 1 , wherein the one or more cannabinoids are present in a pre-mixture with one or more sugar alcohols or one or more sugars.

24. The tableted chewing gum composition according to claim 1 , wherein the one or more cannabinoids form part of a complex with cyclodextrin.

25. The tableted chewing gum composition according to claim 1 , wherein the one or more cannabinoids comprise at least one phytocannabinoid that forms part of an extract.

26. The tableted chewing gum composition according to claim 1 , wherein the chewing gum further comprising terpenes, such as at least one terpene that forms part of an extract.

27. The tableted chewing gum composition according to claim 1 , wherein the one or more cannabinoids comprise at least one isolated cannabinoid.

28. The tableted chewing gum composition according to claim 1 , wherein the one or more cannabinoids comprise at least one water-soluble cannabinoid.

29. A package comprising a tableted chewing gum composition according to claim 1 , the package comprising a material acting as a barrier for the one or more cannabinoids and oxygen.

Assignments (3)
CHANGE OF NAME Recorded Sep 18, 2020
From: MEDCAN PHARMA A/S
To: NORDICCAN A/S
Reel/Frame 053816/0773 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2019
From: BRUUN, HEIDI ZIEGLER; BOESEN, DORTHE SCHACKINGER; ERIKSEN, ANE
To: FERTIN PHARMA A/S
Reel/Frame 049238/0563 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2019
From: FERTIN PHARMA A/S
To: MEDCAN PHARMA A/S
Reel/Frame 049238/0576 →
Continuity (1)
Related Publication 20200276116A1 · Sep 3, 2020
Cited By (2)
US 12,582,602 US 12,629,332